Introduction
The alveolar macrophage (AM) is the most abundant cell in the airway lumen and may be an important contributor to the inflammation associated with pulmonary diseases such as asthma, a'2 Isolated AM respond to a variety of immunological and non-immunological stimuli by generating both acute-phase and pro-inflammatory mediators. The acute-phase mediators include the spasmogens thromboxane A2, leukotriene C4 and platelet activating factor (PAF) as well as reactive oxygen species and lysosomal enzymes which can cause local tissue damage. 3 Among the pro-inflammatory mediators are PAF, leukotriene B 4 and a number of cytokines which are chemoattractant to mast cells, eosinophils and lymphocytes, all of which have been implicated in pulmonary inflammation, a'2 In addition to being directly activated AM can be primed in vitro by agents including LPS 4 and gamma interferon to give an exaggerated response to subsequent stimuli. AM primed in vitro may be comparable with AM from asthmatic subjects which have been shown to release greater amounts of many of the above mediators on stimulation than cells from non-asthmatic subjects. [6] [7] [8] [9] The biochemical mechanisms (Fig. 1B) shows very weak activity against serine and threonine kinases including PKC, PKA and phosphorylase kinase. 17 
